Last reviewed · How we verify
Intradermal microinjections of tranexamic acid
Intradermal microinjections of tranexamic acid is a Small molecule drug developed by Hayat Abad Medical Complex, Peshawar. It is currently in Phase 1 development.
At a glance
| Generic name | Intradermal microinjections of tranexamic acid |
|---|---|
| Sponsor | Hayat Abad Medical Complex, Peshawar |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Comparison of Intradermal Microinjections of Tanexamic Acid and Oral Tranexamic Acid in the Management of Melasma. (EARLY_PHASE1)
- Tranexamic Acid vs. Combination With Fractional Carbon Dioxide Laser in Melasma (PHASE4)
- Tranexamic Acid vs Fractional CO2 Laser in Post-acne Hyperpigmentation (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Intradermal microinjections of tranexamic acid CI brief — competitive landscape report
- Intradermal microinjections of tranexamic acid updates RSS · CI watch RSS
- Hayat Abad Medical Complex, Peshawar portfolio CI
Frequently asked questions about Intradermal microinjections of tranexamic acid
What is Intradermal microinjections of tranexamic acid?
Intradermal microinjections of tranexamic acid is a Small molecule drug developed by Hayat Abad Medical Complex, Peshawar.
Who makes Intradermal microinjections of tranexamic acid?
Intradermal microinjections of tranexamic acid is developed by Hayat Abad Medical Complex, Peshawar (see full Hayat Abad Medical Complex, Peshawar pipeline at /company/hayat-abad-medical-complex-peshawar).
What development phase is Intradermal microinjections of tranexamic acid in?
Intradermal microinjections of tranexamic acid is in Phase 1.